ask="3.30"
ask_size="10000"
average_daily_volume="3230110"
bid="3.22"
bid_size="3100"
book_value="-1.75"
change="-0.02"
change_from_200_day_moving_average="-2.06"
change_from_50_day_moving_average="-1.83"
change_from_52_week_high="-5.75"
change_From_52_week_low="0.06"
change_in_percent="-0.61%"
close="3.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.20"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.35"
high_52_weeks="9.02"
last_trade_date="1/12/2017"
last_trade_price="3.27"
last_trade_size="61579"
last_trade_time="4:00pm"
low="3.21"
low_52_weeks="3.21"
market_capitalization="423.84M"
moving_average_200_day="5.33"
moving_average_50_day="5.10"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.22"
pe_ratio="N/A"
peg_ratio="-0.56"
percent_change_from_200_day_moving_average="-38.64%"
percent_change_from_50_day_moving_average="-35.93%"
percent_change_from_52_week_high="-63.73%"
percent_change_from_52_week_low="+1.87%"
previous_close="3.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="4.08"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="17.94"
stock_exchange="NGM"
symbol="MACK"
volume="3974566"
weeks_range_52="3.21 - 9.02"
